Hypercaloric low-carbohydrate high-fat diet protects against the development of nonalcoholic fatty liver disease in obese mice in contrast to isocaloric Western diet.

Western diet insulin low-carbohydrate diet non-alcoholic fatty liver disease obesity

Journal

Frontiers in nutrition
ISSN: 2296-861X
Titre abrégé: Front Nutr
Pays: Switzerland
ID NLM: 101642264

Informations de publication

Date de publication:
2024
Historique:
received: 07 01 2024
accepted: 11 03 2024
medline: 4 4 2024
pubmed: 4 4 2024
entrez: 4 4 2024
Statut: epublish

Résumé

Obesity and metabolic complications, such as type 2 diabetes and nonalcoholic fatty liver disease (NAFLD), are one of the greatest public health challenges of the 21st century. The major role of high sugar and carbohydrate consumption rather than caloric intake in obesity and NAFLD pathophysiology remains a subject of debate. A low-carbohydrate but high-fat diet (LCHFD) has shown promising results in obesity management, but its effects in preventing NAFLD need to be detailed. This study aims to compare the effects of a LCHFD with a high-fat high-sugar obesogenic Western diet (WD) on the progression of obesity, type 2 diabetes, and nonalcoholic fatty liver disease. Male C57BL/6J mice were initially fed a WD for 10 weeks. Subsequently, they were either switched to a LCHFD or maintained on the WD for an additional 6 weeks. Hepatic effects of the diet were explored by histological staining and RT-qPCR. After the initial 10 weeks WD feeding, LCHF diet demonstrated effectiveness in halting weight gain, maintaining a normal glucose tolerance and insulin levels, in comparison to the WD-fed mice, which developed obesity, glucose intolerance, increased insulin levels and induced NAFLD. In the liver, LCHFD mitigated the accumulation of hepatic triglycerides and the increase in Fasn relative gene expression compared to the WD mice. Beneficial effects of the LCHFD occurred despite a similar calorie intake compared to the WD mice. Our results emphasize the negative impact of a high sugar/carbohydrate and lipid association for obesity progression and NAFLD development. LCHFD has shown beneficial effects for NAFLD management, notably improving weight management, and maintaining a normal glucose tolerance and liver health.

Identifiants

pubmed: 38571752
doi: 10.3389/fnut.2024.1366883
pmc: PMC10987868
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1366883

Informations de copyright

Copyright © 2024 Charlot, Bringolf, Mallard, Charles, Niederhoffer, Duteil, Pagano, Geny and Zoll.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Anouk Charlot (A)

Biomedicine Research Center of Strasbourg (CRBS), UR 3072, "Mitochondrie, Stress oxydant et Plasticité musculaire", University of Strasbourg, Strasbourg, France.
Faculty of Sport Sciences, University of Strasbourg, Strasbourg, France.

Anthony Bringolf (A)

Biomedicine Research Center of Strasbourg (CRBS), UR 3072, "Mitochondrie, Stress oxydant et Plasticité musculaire", University of Strasbourg, Strasbourg, France.

Joris Mallard (J)

Biomedicine Research Center of Strasbourg (CRBS), UR 3072, "Mitochondrie, Stress oxydant et Plasticité musculaire", University of Strasbourg, Strasbourg, France.
Faculty of Sport Sciences, University of Strasbourg, Strasbourg, France.
Institute of Cancerology Strasbourg Europe (ICANS), Strasbourg, France.

Anne-Laure Charles (AL)

Biomedicine Research Center of Strasbourg (CRBS), UR 3072, "Mitochondrie, Stress oxydant et Plasticité musculaire", University of Strasbourg, Strasbourg, France.
Faculty of Medicine, University of Strasbourg, Strasbourg, France.

Nathalie Niederhoffer (N)

Biomedicine Research Center of Strasbourg (CRBS), UR7296, NeuroCardiovascular Pharmacology and Toxicology Laboratory (LPTNC), University of Strasbourg, Strasbourg, France.

Delphine Duteil (D)

University of Strasbourg, CNRS, Inserm, IGBMC UMR 7104-UMR-S 1258, Illkirch, France.

Allan F Pagano (AF)

Biomedicine Research Center of Strasbourg (CRBS), UR 3072, "Mitochondrie, Stress oxydant et Plasticité musculaire", University of Strasbourg, Strasbourg, France.
Faculty of Sport Sciences, University of Strasbourg, Strasbourg, France.

Bernard Geny (B)

Biomedicine Research Center of Strasbourg (CRBS), UR 3072, "Mitochondrie, Stress oxydant et Plasticité musculaire", University of Strasbourg, Strasbourg, France.
Service de Physiologie et explorations fonctionnelles, University Hospital of Strasbourg, Strasbourg, France.

Joffrey Zoll (J)

Biomedicine Research Center of Strasbourg (CRBS), UR 3072, "Mitochondrie, Stress oxydant et Plasticité musculaire", University of Strasbourg, Strasbourg, France.
Faculty of Medicine, University of Strasbourg, Strasbourg, France.
Service de Physiologie et explorations fonctionnelles, University Hospital of Strasbourg, Strasbourg, France.

Classifications MeSH